DENKI

Welcome to the Brand page for “DENKI”, which is offered here for In the statement, classes 1 and 42 have been corrected per the restriction dated march 19, 2020, and per the fnote dated april 13, 2020.;chemical products for use in industry and science, [ all aforementioned goods only for dual enkephalinase inhibitors ] * all the aforesaid goods exclusively in connection with dual enkephalinase inhibitors *;scientific technological services namely, scientific research, analysis, testing in the field of endogenous opioid peptides; scientific research and design and development services related to the inhibition of the degradation of endogenous opioid peptides, all in the medical and pharmaceutical fields; development of medicines for [ others ] * third parties * ; medicine discovery services in the nature of development of pharmaceutical preparations, [ all aforementioned services only for dual enkephalinase inhibitors ] * all the aforesaid services exclusively in connection with dual enkephalinase inhibitors *;.

Its status is currently believed to be active. Its class is unavailable. “DENKI” is believed to be currently owned by “PHARMALEADS”.